about
IPFA
Mission and Vision
Our Objectives and who we work with
Board members
Secretariat
IPFA Members
and Membership
Members
Membership Application
IPFA Awards
facts about
Plasma / Fractionation
From Plasma to Medicines by Fractionation
Safety and Quality First
Strategy for Secure and Sustainable Plasma Supply
IPFA Position Papers
events and
Activities
IPFA Events
Other Events
IPFA Proceedings
Members login
about
IPFA
Mission and Vision
Our Objectives and who we work with
Board members
Secretariat
IPFA Members
and Membership
Members
Membership Application
IPFA Awards
facts about
Plasma / Fractionation
From Plasma to Medicines by Fractionation
Safety and Quality First
Strategy for Secure and Sustainable Plasma Supply
IPFA Position Papers
events and
Activities
IPFA Events
Other Events
IPFA Proceedings
Other Publications
IPFA Donor Information Standard: Plasma Derived Medicinal Products (PDMPs)
April 2019
IPFA Donor Information Standard: Plasma Derived Medicinal Products (PDMPs)
The Organization of transfusion and fractionation in France and its regulation. Dr Françoise Rossi. Review article
September 2018
Annals of Blood, Ann Blood 2018;3:37.
Creutzfeldt-Jakob disease and blood transfusion safety C.R. Seed e.a. Review article
January 2018
Vox Sanguinis (2018) DOI: 10.1111/vox.12631
Strengers PFW. Evidence-based clinical indications of plasma products and future prospects
December 2017
Annals of Blood.2017;2:20. doi: 10.21037/aob.2017.12.03
Qiu Y, Vuk T, Bust L, Strengers P, Seidl Chr. Self-Inspection and classification of non-compliances
December 2017
ISBT Science Series 2017,0,1-5. DOI:10.1111/voxs.12402
Domanović D, Tedder R, Blümel J, Zaaijer H, Gallian P, Niederhauser C, Sauleda Oliveras S, O’Riordan J, Boland F, Harritshøj L, Nascimento MSJ, Ciccaglione AR, Politis C, Adlhoch C, Flan B, Oualikene-Gonin W, Rautmann G, Strengers P, Hewitt P. Hepatitis E and blood donation safety in selected European countries: a shift to screening?
April 2017
Euro Surveill. 2017;22(16):pii=30514. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.16.30514
Strengers PFW, Klein HG. Plasma is a Strategic Resource
December 2016
Transfusion 2016; 56:3133–3137
Burnouf T, Strengers PFW. Risks of inhibitors from recombinant factor VIII: a quarter of a century to reach the conclusion
June 2016
J Thromb Haemost 2016; 14: 2073–4
© 2025 Copyright
creaza
/ IPFA
Privacy policy
|
Disclaimer